Debra Perelman (BBBY) adds 32,174 shares and new RSU grant in Form 4
Rhea-AI Filing Summary
Bed Bath & Beyond director Debra Golding Perelman reported equity compensation activity, acquiring shares through RSU vesting and receiving new awards. On May 15, 2026, 26,873 restricted stock units converted into the same number of common shares at a price of $0.00, increasing her direct common stock holdings to 32,174 shares.
On May 14, 2026, she received a grant of 35,181 restricted stock units, each representing a contingent right to one common share that vests at the close of business on May 14, 2027. She also holds 530 common stock warrants that were originally issued on October 7, 2025 in a pro-rata distribution to all common shareholders, each exercisable for one common share at an exercise price of $15.50 per warrant until October 7, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 26,873 | $0.00 | -- |
| Exercise | Common Stock | 26,873 | $0.00 | -- |
| Grant/Award | Restricted Stock Units | 35,181 | $0.00 | -- |
| Grant/Award | Common Stock Warrant | 530 | $0.00 | -- |
Footnotes (1)
- Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vested at the close of business on May 15, 2026. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein. Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest at the close of business on May 14, 2027. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein. Represents warrants that were originally issued on October 7, 2025 as a pro-rata distribution to all holders of common stock. Each warrant entitles the holder to purchase one share of common stock at an exercise price of $15.50 per warrant. This distribution was exempt from immediate reporting under Section 16.